Evidence map›Paper›PMID 24355864›Full record

ArticleJournal of innate immunity2014

Myeloperoxidase directs properdin-mediated complement activation.

Joseph O'Flynn, Karen O Dixon, Maria C Faber Krol, Mohamed R Daha, Cees van Kooten

Open access · bronzeAbstract read
In one paragraph

Article in Journal of innate immunity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Effects of dietary supplementation ofFish and shellfish immunology reports · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. The interplay between neutrophils, complement, and microthrombi in COVID-19.Best practice & research. Clinical rheumatology · 2021
    Review
  18. Article
  19. Review
  20. Mechanisms of haemolysis-induced kidney injury.Nature reviews. Nephrology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Joseph O'FlynnDepartment of Nephrology, Leiden University Medical Center, Leiden, The Netherlands.
Karen O Dixon
Maria C Faber Krol
Mohamed R Daha
Cees van Kooten
Leiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neutrophils and complement are key members of innate immunity. The alternative pathway (AP) of complement consists of C3, factor B, factor D and properdin, which amplifies AP activation. AP has been implicated in many neutrophil-mediated diseases, such as anti-neutrophil cytoplasmic antibody-associated vasculitis. The exact mechanism by which the AP and neutrophils interact remains largely unstudied. We investigated the ability of the AP to interact with neutrophil components which can be exposed and released upon activation. Our studies focused on neutrophil enzymes, including myeloperoxidase (MPO), proteinase 3 (PR3), azurocidin, elastase, lysozyme and cathepsin G. All enzymes except for azurocidin were able to bind properdin. However, only MPO could induce C3 activation. MPO mediated AP complement activation in the presence of MgEGTA compared to the EDTA control. This activation resulted in C3 deposition and required properdin to occur. Furthermore, we could show that MPO binds properdin directly, which then serves as a focus for AP activation. In summary, properdin can directly interact with neutrophil components. MPO demonstrates the ability to activate the AP which is dependent on properdin. Finally, MPO is capable of inducing properdin-initiated C3 and C5b-9 deposition in vitro.

Indexed as

Complement Pathway, AlternativeAntimicrobial Cationic PeptidesAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisBlood ProteinsCarrier ProteinsCathepsin GComplement C3Complement Membrane Attack ComplexHumansImmunity, InnateMuramidaseMyeloblastinNeutrophilsPancreatic ElastasePeroxidaseProperdinAntimicrobial Cationic PeptidesAZU1 protein, humanBlood ProteinsCarrier ProteinsCathepsin GComplement C3Complement Membrane Attack ComplexMuramidaseMyeloblastinPancreatic ElastasePeroxidaseProperdin

Identifiers

PMID24355864
PMCPMC6741500
OpenAlexW2017004497

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.